Characteristic | CsA (N = 58) | Con (N = 120) | P value |
---|---|---|---|
Patients’ age at OPU (y) | 32.0 (29.0-34.3) | 31.5 (29.0–35.0) | 0.698 |
Patients’ age during ET (y) | 33.5 (30.0-35.3) | 32.0 (30.0–36.0) | 0.777 |
BMI (kg/m2) | 22.5 ± 3.3 | 22.8 ± 3.5 | 0.596 |
Basal FSH (IU/mL) | 5.9 (4.3–7.4) | 6.0 (5.0–8.0) | 0.225 |
No. of ET cycles | 2.0 (2.0–3.0)* | 2.0 (2.0–2.0) | 0.027 |
No. of total embryos cryopreserved | 6 (4–8) | 5 (3–6) | 0.138 |
No. of current cycle embryos transferred | 2.0 (2.0–3.0) | 2.0 (2.0–2.0) | 0.230 |
No. of total prior embryos transferred | 2.0 (2.0–2.0)* | 2.0 (1.0–2.0) | 0.006 |
Endometrium thickness(mm) | 9.0 (8.0-10.3) | 9.0 (8.0-10.5) | 0.632 |
Causes of Infertility | > 0.05 | ||
Female (%) | 65.5 (38) | 69.2 (83) | |
Diminished ovarian reserve (%) | 13.1 (5) | 14.5 (12) | |
Ovulation disease (%) | 18.4 (7) | 19.3 (16) | |
Tubal disease (%) | 63.2 (24) | 60.2 (50) | |
Unexplained (%) | 5.3 (2) | 6.0 (5) | |
Male (%) | 1.7 (1) | 5.8 (7) | |
Female and Male (%) | 27.6 (16) | 22.5 (27) | |
Others (%) | 5.2 (3) | 2.5 (3) | |
Primary (%) | 48.3 (28) | 55.0 (66) | |
Secondary (%) | 51.7 (30) | 45.0 (54) | |
Development stage of ET embryos | > 0.05 | ||
Day3 (%) | 46.6 (27) | 50.0 (60) | |
Day5 (%) | 15.5 (9) | 14.2 (17) | |
Day6 (%) | 37.9 (22) | 35.8 (43) | |
Endometrium morphology | > 0.05 | ||
A (%) | 58.6 (34) | 58.3 (70) | |
A- (%) | 20.7 (12) | 31.7 (38) | |
Others (%) | 20.7 (12) | 10.0 (12) |